U.S. Consumer Services Stock News

Snap-on reported fourth-quarter 2025 results with sales of US$1,231.9 million and diluted EPS of US$4.94, alongside a US$2.44 quarterly dividend declared for payment on March 10, 2026 to shareholders of record on February 24, 2026. While revenue growth was modest and earnings eased slightly for the full year, Snap-on’s uninterrupted quarterly dividend record since 1939 underscores how management is prioritizing consistent shareholder returns amid a turbulent demand backdrop. Now we’ll assess...

PHINIA Inc. (NYSE:PHIN) reported year over year growth across key business segments in 2025. The company recorded three consecutive quarters of growth in both Fuel Systems and Aftermarket segments. Management reduced debt, improved leverage, and expressed optimism for 2026. Leadership is targeting further market share gains in areas such as Gasoline Direct Injection and alternative fuels. PHINIA, trading as NYSE:PHIN, focuses on Fuel Systems and Aftermarket products that support internal...

What ABM Industries (ABM) investors may be watching now ABM Industries (ABM) recently closed at $44.51, with shares showing a 2.46% move over the past day, a small decline over the past month, and a gain across the past 3 months. See our latest analysis for ABM Industries. That 2.46% 1 day share price gain comes after a 6.41% 7 day share price pullback. The 90 day share price return of 10.42% suggests momentum has been rebuilding even as the 1 year total shareholder return of 13.92% remains...

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...

Wondering if Klarna Group at US$18.11 is a bargain or a value trap? This article walks you through what the current price might really be telling you. The stock has recently seen sharp moves, with a 7 day return of an 11.7% decline and a 30 day return of a 37.6% decline, and it sits 36.6% below its year to date level. Recent headlines around Klarna Group have kept investor attention on the business model and competitive position, which helps frame these price swings. This article uses that...

Crane NXT recently reported past quarterly results showing around 20% year-on-year sales growth in Q4 2025 and 11% for 2025 overall, driven by strong demand in its currency and authentication technology businesses, new wins across 20 currency denominations, and renewed multiyear contracts with major sports leagues. The company is also expanding capacity in its international currency operations and moving to acquire Antares Vision by mid-2026, highlighting how its micro-optics and...

On 12 February 2026, BioLife Solutions, Inc. announced a multi-year agreement to distribute Qkine Limited’s cytokine and growth factor products globally for cell and gene therapy manufacturing, with plans to integrate select products into BioLife’s CellSeal® Connect vial system. This deal broadens BioLife’s reach into the US$500 million cytokines market, which third-party research suggests could reach about US$1.00 billion by 2030, directly linking its biopreservation tools with critical CGT...

NeoVolta (NEOV) has just posted its Q2 2026 numbers, with Q1 2026 revenue at US$6.7 million and a net loss of US$1.2 million, translating into basic EPS of a US$0.04 loss. The company has seen quarterly revenue move from US$0.6 million in Q1 2025 through US$1.1 million in Q2 2025, US$2.0 million in Q3 2025 and US$4.8 million in Q4 2025 to US$6.7 million in Q1 2026, while EPS over the same stretch ranged from a loss of US$0.03 to a loss of US$0.05 per share. For investors, the latest set of...

Tapestry (NYSE:TPR) reported strong quarterly results, highlighting global customer acquisition and growing Gen Z engagement. Management pointed to increased effectiveness of its direct to consumer approach, marketing efforts, and product development. The company raised its full year revenue outlook, citing higher operating margins and improved profitability. Tapestry, the owner of several luxury and premium brands, is drawing attention after this update, especially given its recent share...

If you are wondering whether TPG’s share price reflects its underlying worth right now, you are not alone. This article is here to frame the key valuation questions you might be asking. After reaching a recent close of US$49.53, the stock has seen a 10% decline over the last 7 days and a 26.2% decline over the last 30 days, while still showing a 64.5% return over 3 years and mixed results over shorter periods including year to date and the last 12 months. Recent news coverage around TPG has...

Why CSW Industrials Is Back On Investors’ Radar Investor sentiment toward CSW Industrials (CSW) has shifted, with buyers returning after a stretch of earnings misses, as attention turns to the company’s multi-year revenue and net income growth and longer term outlook. See our latest analysis for CSW Industrials. At a share price of US$309.48, CSW Industrials has recently seen a 6.63% 7 day share price return but a 6.53% 30 day share price decline, while its 90 day share price return of 28.25%...

Why Kingsoft Cloud Holdings (KC) Is Back on Investor Radars Kingsoft Cloud Holdings (NasdaqGS:KC) is drawing fresh interest after reporting revenue growth of 31.40% and attracting consistent buy ratings from analysts, even as profitability and cash flow remain key watchpoints for investors. See our latest analysis for Kingsoft Cloud Holdings. Recent trading has been volatile, with a 7 day share price return of 11.99% and a 30 day gain of 21.68%. However, the 1 year total shareholder return...

Curtiss-Wright (NYSE:CW) has been selected by Boeing to supply mission computer technology for the U.S. Air Force C-17 Globemaster III upgrade program. The contract, valued at over $400 million, supports modernization of a key airlift platform used by the U.S. and allied forces. This award expands Curtiss-Wright's role in military aerospace technology and deepens its relationship with Boeing. Curtiss-Wright comes into this contract win with shares at $684.22, after a 1-year return of 112.1%...

On February 4, 2026, Oncolytics Biotech announced that the FDA granted Fast Track Designation to pelareorep combined with bevacizumab and FOLFIRI for second-line treatment of KRAS-mutant, microsatellite-stable metastatic colorectal cancer. The designation is backed by clinical data showing pelareorep-based therapy delivered higher response rates and longer survival measures than existing standard-of-care options in this hard-to-treat subgroup. With the FDA’s Fast Track Designation in place,...

In recent weeks, Fidelity National Information Services has been recognized with multiple industry honors, including TMI Awards for Best Risk Management Solution and Best Cash & Treasury Management Solution, and leadership positions in IDC and Chartis assessments of treasury, risk and asset-liability management technology. These accolades, alongside renewed analyst coverage, underscore how FIS’s capabilities in AI-enabled treasury and risk tools are shaping perceptions of its role in...

United Natural Foods (UNFI) recently drew more than 3,400 retailers and suppliers to its 2026 Spring and Summer Selling Show in Orlando, highlighting consumer driven trends and a wave of new private label products. See our latest analysis for United Natural Foods. At a share price of US$40.30, United Natural Foods has seen a 20.59% year to date share price return and a 49.76% total shareholder return over five years. The recent 15.04% 30 day share price return suggests momentum has picked up...

Event context and recent share performance Enova International (ENVA) has caught investor attention after recent share price swings, with a gain of about 24% over the past 3 months contrasting with a 5% decline over the past month. See our latest analysis for Enova International. Looking beyond the recent pullback, Enova International’s share price return over the past quarter has been strong, and that sits alongside a very large 5 year total shareholder return. This suggests sentiment has...

Recent analyst coverage of Olema Pharmaceuticals (OLMA) with a favorable stance, combined with detailed updates on its OPERA-01 Phase 3 timeline and commercialization plans, has brought this breast cancer focused biotech further onto investors’ radars. See our latest analysis for Olema Pharmaceuticals. Despite the recent pullback, with a 1 day share price return of 4.9% decline and a 30 day share price return of 16.8% decline to US$22.59, Olema’s 90 day share price return of 165.1% and very...

Warrior Met Coal (NYSE:HCC) has started longwall production at its Blue Creek mine around eight months ahead of its original schedule. The company reports that this early start is supporting record production, sales, and earnings in 2025 in what it describes as a challenging market. Warrior Met Coal has also finalized two federal coal leases that add major coal reserves to its asset base. Management highlights these milestones as key drivers for planned production and sales expansion in 2026...

DraftKings (DKNG) closed out FY 2025 with Q4 revenue of US$1.99b and basic EPS of US$0.28, while trailing twelve month EPS edged into positive territory at US$0.01 on revenue of US$6.05b. This helped set the tone for a results season where profitability is firmly in focus. The company has seen quarterly revenue move from US$1.39b in Q4 2024 to US$1.99b in Q4 2025, with basic EPS shifting from a loss of US$0.28 per share to earnings of US$0.28 per share over the same period. This puts the...